CVS CEO Joyner touts 'cautious and prudent' approach after stock gains 15% following earnings beat
CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...
CVS CEO Joyner: 'No one has demonstrated more success than the PBMs'
CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...
CVS needs a more streamlined healthcare services strategy: CEO Joyner
CVS Health CEO David Joyner sees a way to create a more efficient healthcare professional network under the CVS umbrella.
Fierce Healthcare8d
CVS CEO David Joyner mounts defense of PBM industry amid ongoing scrutiny
CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...
Managed Healthcare Executive8d
David Joyner: CVS Health is on a Pharmacy Transformation Journey
Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...
Fierce Healthcare2d
CVS taps Ed DeVaney to lead its Caremark PBM
CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...
Corporate America's Real Worries About Trump Are Buried In Annual Reports
Yet the same day, CVS filed its annual report to shareholders with a new paragraph about “uncertainty” around changing health-care rules. The company warned that “efforts to reform federal government ...
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.